Ikarian Capital, LLC - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 42 filers reported holding SOLENO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$29,000
-42.0%
128,454
+5.6%
0.00%
-42.9%
Q4 2021$50,000
-55.4%
121,6940.0%0.01%
-12.5%
Q3 2021$112,000
-20.0%
121,694
-0.6%
0.01%
-27.3%
Q2 2021$140,000
-9.7%
122,4620.0%0.01%
+120.0%
Q1 2021$155,000
-34.3%
122,4620.0%0.01%
-50.0%
Q4 2020$236,000
-95.9%
122,462
-95.2%
0.01%
-97.8%
Q2 2020$5,696,0002,565,6010.45%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$9,500,0002.16%
Nantahala Capital Management 9,765,129$9,028,0000.28%
ORACLE INVESTMENT MANAGEMENT INC 2,132,000$1,971,0000.24%
Granite Point Capital Management, L.P. 701,838$649,0000.05%
OPPENHEIMER & CO INC 639,140$591,0000.01%
Ikarian Capital, LLC 121,694$112,0000.01%
Warberg Asset Management LLC 30,000$28,0000.01%
Levy Wealth Management Group, LLC 10,000$9,0000.01%
Ergoteles LLC 74,525$69,0000.00%
TWO SIGMA ADVISERS, LP 744,000$688,0000.00%
View complete list of SOLENO THERAPEUTICS INC shareholders